Previous 10 | Next 10 |
Quick Take ACell ( ACLL ) has filed to raise $75 million from the sale of its common stock, according to an amended registration statement . The company develops and sells wound treatment systems for various tissue care applications. ACLL was growing revenue sharply but has since felt t...
Quick Take ACell ( ACLL ) has filed to raise $86.25 million in an IPO of its common stock, according to an S-1 registration statement . The firm develops and sells various wound care products for post-surgical applications. ACLL has experienced a drop in sales as the Covid-19 pandemic ...
CANTON, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
Gainers: ARCA biopharma (NASDAQ: ABIO ) +174% . More news on: ARCA biopharma, Inc., Monaker Group, Inc., Triumph Group, Inc., Stocks on the move, , Read more ...
Mersana Therapeutics (NASDAQ: MRSN ) +42% as XMT-1536 shows positive action in ovarian cancer. More news on: Mersana Therapeutics, Inc., Phunware, Inc., Luckin Coffee Inc., Stocks on the move, , Read more ...
Image source: The Motley Fool. Organogenesis Holdings Inc (NASDAQ: ORGO) Q1 2020 Earnings Call May 11, 2020 , 5:00 p.m. ET Operator Continue reading
Organogenesis Holdings, Inc. (ORGO) Q1 2020 Earnings Conference Call May 11, 2020, 17:00 ET Company Participants Gary Gillheeney - President, CEO & Director Timothy Cunningham - CFO Conference Call Participants Matthew Miksic - Crédit Suisse Ryan Zimmerman - BTIG ...
Organogenesis Holdings (NASDAQ: ORGO ): Q1 GAAP EPS of -$0.16 misses by $0.03 . More news on: Organogenesis Holdings Inc., Earnings news and commentary, Read more ...
CANTON, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, tod...
CANTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...